Two Phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo.
21 Oct, 2022 | 13:03h | UTCTwo Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo – HealthDay